For decades, advocates of medicinal cannabis have pointed to the plant’s potential anti-cancer properties. In recent years, governments around the world, including in the UK, have begun to allow the use of medicinal cannabis products for the treatment of a limited number of conditions. However, cannabis products may only be prescribed for chemotherapy-induced nausea in relation to cancer.
Now, evidence published by the University of Newcastle in Australia has revealed new findings into the plant’s anti-cancer potential. The tests carried out at the University and the Hunter Medical Research Institute showed that a modified form of cannabis had the potential to kill or inhibit cancer cells. In addition, the high-CBD form of cannabis did not impact other natural cells.
A low-THC form of the cannabis plant known as ‘Eve’, produced by Australian Natural Therapeutics Group was tested by cancer researcher Dr Matt Dun at the New South Wales university. The cannabis variety is high in CBD and contains less than 1% THC.
Past evidence has suggested that THC – the most prevalent cannabinoid found within the cannabis plant – was the main source of the plant’s potential anti-cancer properties. However, the lab tests carried out in collaboration with the Australian Natural Therapeutics Group, revealed that strains high in CBD may be more effective at killing cancer cells.
Read full article here: https://canex.co.uk/cannabis-and-cancer-cells-new-research-from-australian-university/